Collegium Pharma management joins Morgan Stanley Global Healthcare Conference fireside chatPUBT·Sep 8 at 12:04 PMCOLL-0.74%MS+0.81%
Top 3 Health Care Stocks Which Could Rescue Your Portfolio In Q3benzinga_article·Sep 3 at 10:09 AMAHG+14.93%UTHR-1.34%
Barclays Sticks to Their Buy Rating for Collegium Pharmaceutical (COLL)Tip Ranks·Aug 19 at 07:27 AMCOLL-0.74%
The Infrastructure Bottleneck: When AI Software Meets Physical RealityGlobal Report·Aug 18 at 10:12 AMHUBS+0.80%DOCU-0.23%
Collegium Announces $50 Million Accelerated Share Repurchase ProgramUnusual Whales·Aug 13 at 11:32 AMCOLL-0.74%JEF-3.65%
Collegium Q2 2026 Earnings: Acquisition Costs Push GAAP Results Into a LossTradingKey·Aug 6 at 12:26 PMCOLL-0.74%
Collegium turns to GAAP net loss of $15.1 million in Q2 FY26; revenue rises 6% to $199.9 millionPUBT·Aug 6 at 11:35 AMCOLL-0.74%
Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company ProgressUnusual Whales·Aug 6 at 11:34 AMCOLL-0.74%
Collegium Pharmaceutical (COLL) Reports Earnings Tomorrow: What To ExpectStock Story·Aug 5 at 03:36 AMCOLL-0.74%
Collegium Pharmaceutical to report Q2 2026 results, host earnings callPUBT·Jul 23 at 12:05 PMCOLL-0.74%
Collegium Pharma To Relocate Corporate Headquarters To Downtown Boston In 2027rttnews·Jul 20 at 02:31 PMCOLL-0.74%
DivcoWest Welcomes Collegium Pharmaceutical to One LincolnUnusual Whales·Jul 20 at 12:47 PMCOLL-0.74%
